Alkem Laboratories Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1973.
1973 Mumbai, Maharashtra, India Active
Last Updated:
About Alkem Laboratories Limited

Alkem Laboratories Limited, a active public limited company, was established on 08 August 1973 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L00305MH1973PLC174201. Registered under ROC Roc Mumbai. it is listed on BSE: 539523 and NSE: ALKEM. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹23.91 Cr.

Formerly known as Alkem Laboratories Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹10,053.71 Cr and a net worth of ₹10,554.61 Cr. Employing 18,498 professional, Its leadership includes Rajeev Kher (Director), Diwakar Gupta (Director), Madhurima Singh (Whole-Time Director). Past directors included Dheeraj Sharma, Samprada Singh, Rajeev Kher. It holds ₹1,085.77 Cr open charges and ₹4,919.56 Cr settled loans. Its latest AGM occurred on 25 August 2025, with the balance sheet filed on 31 March 2025. It is based at Alkem House, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L00305MH1973PLC174201

  • Registration Number

    174201

  • Incorporation Date

    08 August 1973

  • Authorized Capital

    ₹50.00 Cr

  • Paid-Up Capital

    ₹23.91 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed (BSE: 539523, NSE: ALKEM)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 Cr
  • Paid Up Capital ₹ 23.91 Cr
  • Company Age 52 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1,085.77 Cr
  • Satisfied Charges ₹ 4,919.56 Cr
  • Revenue Growth **** 7.86%
  • Profit Growth **** 54.01%
  • Ebitda **** 42.72%
  • Net Worth 12.89%
  • Total Assets **** 10.26%
Company report

Alkem Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Alkem Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Alkem Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Rajeev Kher Director 09 Aug 2024 Current
Diwakar Gupta Director 13 Jul 2025 Current
Madhurima Singh Whole-Time Director 20 Dec 2021 Current
Sarvesh Singh Whole-Time Director 11 Nov 2019 Current
Basudeo Narayan Singh Whole-Time Director 08 Aug 1973 Current
Mritunjay Kumar Singh Whole-Time Director 11 Feb 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 08 Sep 2017 Past
Pramod Abcsdd Director 27 Jul 2019 Past
Pramod Abcsdd Additional Director 02 Oct 2024 Past
Pramod Abcsdd Additional Director 13 Jul 2025 Past
Pramod Abcsdd Additional Director 13 Jul 2015 Past
Pramod Abcsdd Additional Director 20 Dec 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Alkem Laboratories.

Alkem Laboratories Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.86% increase. The company also saw a substantial improvement in profitability, with a 54.01% increase in profit. The company's net worth Soared by an impressive increase of 12.89%.

Alkem Laboratories revenue growth over time
Alkem Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
7.86%
*******
*******
*******
*******
Revenue from Operations
*******
7.66%
*******
*******
*******
*******
Total Assets
*******
10.26%
*******
*******
*******
*******
Profit or Loss
*******
54.01%
*******
*******
*******
*******
Net Worth
*******
12.89%
*******
*******
*******
*******
EBITDA
*******
42.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Alkem Laboratories?

In 2023, Alkem Laboratories had a promoter holding of 57.16% and a public holding of 42.82%. The company had 5 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹10,857,699,999.00

Satisfied Charges

₹49,195,614,059.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 341.96 Cr
  • Others : 288.00 Cr
  • Hdfc Bank Limited : 270.32 Cr
  • State Bank Of India : 100.20 Cr
  • Bank Of India : 85.00 Cr
  • Others : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
15 Jul 2024 Others ₹100.00 Cr Open
26 Feb 2024 Others ₹108.00 Cr Open
07 Oct 2023 Bank Of India ₹85.00 Cr Open
24 Aug 2023 Others ₹80.00 Cr Open
27 Mar 2023 Hdfc Bank Limited ₹270.32 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Alkem Laboratories?

Alkem Laboratories has a workforce of 18498 employees as of Nov 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Alkem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alkem Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Alkem Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    The activity Alkem Laboratories Limited last Annual general meeting of members was held on 25 Aug 2025 as per latest MCA records. was completed.

  • Director Appointment

    Diwakar Gupta was appointed as a Director was appointed as a Director on 13 Jul 2025 & has been associated with this company since 7 months 20 days . was recorded as a recent event.

  • Director Appointment

    The activity Neela Bhattacherjee was appointed as a Director was appointed as a Director on 13 Jul 2025 & has been associated with this company since 7 months 20 days . was completed.

  • Director Appointment

    The activity Laxmana Ranjal Shenoy was appointed as a Director was appointed as a Director on 13 Jul 2025 & has been associated with this company since 7 months 20 days . was completed.

  • Balance Sheet

    Progress on Alkem Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Rajeev Kher was appointed as a Director was appointed as a Director on 09 Aug 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Alkem Laboratories Limited?

The CIN of Alkem Laboratories Limited is L00305MH1973PLC174201.

Where is Alkem Laboratories Limited headquartered?

Alkem Laboratories Limited is headquartered at Alkem House, Senapati Bapat Marg Lower Parel, Mumbai, Maharashtra, 400013.

When was Alkem Laboratories Limited incorporated?

Alkem Laboratories Limited was incorporated on 08 August 1973.

Who are the current directors of Alkem Laboratories Limited?
What is the primary industry of Alkem Laboratories Limited?

The primary industry of Alkem Laboratories Limited is Manufacturing.

Is Alkem Laboratories Limited a listed company?

Alkem Laboratories Limited is listed. It is listed on BSE: 539523 and NSE: ALKEM.

What is the capital structure of Alkem Laboratories Limited?

The authorized capital of Alkem Laboratories Limited is ₹50.00 Cr, and the paid-up capital is ₹23.91 Cr.

What is the compliance status of Alkem Laboratories Limited?

The compliance status of Alkem Laboratories Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available